ABSTRACT
BACKGROUND
Many older adults in the U.S. do not receive appropriate colorectal cancer (CRC) screening. Although primary care physicians’ recommendations to their patients are central to the screening process, little information is available about their recommendations in relation to guidelines for the menu of CRC screening modalities, including fecal occult blood testing (FOBT), flexible sigmoidoscopy (FS), colonoscopy, and double contrast barium enema (DCBE). The objective of this study was to explore potentially modifiable physician and practice factors associated with guideline-consistent recommendations for the menu of CRC screening modalities.
METHODS
We examined data from a nationally representative sample of 1266 physicians in the U.S. surveyed in 2007. The survey included questions about physician and practice characteristics, perceptions about screening, and recommendations for age of initiation and screening interval for FOBT, FS, colonoscopy and DCBE in average risk adults. Physicians’ screening recommendations were classified as guideline consistent for all, some, or none of the CRC screening modalities recommended. Analyses used descriptive statistics and polytomous logit regression models.
RESULTS
Few (19.1%; 95% CI:16.9%, 21.5%) physicians made guideline-consistent recommendations across all CRC screening modalities that they recommended. In multivariate analysis, younger physician age, board certification, north central geographic region, single specialty or multi-specialty practice type, fewer patients per week, higher number of recommended modalities, use of electronic medical records, greater influence of patient preferences for screening, and published clinical evidence were associated with guideline-consistent screening recommendations (p < 0.05).
CONCLUSIONS
Physicians’ CRC screening recommendations reflect both overuse and underuse, and few made guideline-consistent CRC screening recommendations across all modalities they recommended. Interventions that focus on potentially modifiable physician and practice factors that influence overuse and underuse and address the menu of recommended screening modalities will be important for improving screening practice.
Similar content being viewed by others
REFERENCES
Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603–1607.
Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schumann LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365–1371.
Hardcastle JD, Thomas WM, Chamberlain J, Pye G, Sheffeild J, James PD, et al. Randomized, controlled trial of faecal occult blood screening for colorectal cancer Results for first 107, 349 subjects. Lancet. 1989;1:1160–1164.
Kronborg O, Fenger C, Olsen J, Jorgensen OD. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467–1471.
Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst. 1993;85:1311–1318.
U.S.Preventive Services Task Force. Guide to Clinical Preventive Services: Report of the US Preventive Services Task Force. 2nd ed. Baltimore, MD: Williams & Wilkins; 1996.
Byers T, Levin B, Rothenberger D, Dodd GD, Smith RA. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer. CA Cancer J Clin. 1997;47:154–160.
Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112:594–642.
Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2002;137:132–141.
Smith RA, von Eschenbach AC, Wender R, Levin B, Byers T, Rothenberger D, et al. American Cancer Society guidelines on screening and surveillance for the early detection of adenomatous polyps and colorectal cancer: update 2001. CA Cancer J Clin. 2001;51:44–54.
National Committee for Quality Assurance (NCQA). Accessed July 20, 2009. HEDIS® - Health Plan Employer Data and Information Set. 2009.
Meissner HI, Breen N, Klabunde CN, Vernon SW. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomark Prev. 2006;15:389–394.
Shapiro JA, Seeff LC, Thompson TD, Nadel MR, Klabunde CN, Vernon SW. Colorectal cancer test use from the 2005 National Health Interview Survey. Cancer Epidemiol Biomark Prev. 2008;17:1623–1630.
Klabunde CN. Trends in the use and quality of colorectal cancer screening in the U.S. 2010. NIH State of the Science Conference: Enhancing Use and Quality of Colorectal Cancer Screening. 2-2-2010.
Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst. 1997;89:1406–1422.
Zapka JG, Puleo E, Vickers-Lahti M, Luckmann R. Healthcare system factors and colorectal cancer screening. Am J Prev Med. 2002;23:28–35.
Klabunde CN, Schenck AP, Davis WW. Barriers to colorectal cancer screening among Medicare consumers. Am J Prev Med. 2006;30:313–319.
Levy BT, Dawson J, Hartz AJ, James PA. Colorectal cancer testing among patients care for by Iowa family physicians. Am J Prev Med. 2006;31:193–201.
Hawley ST, Levin B, Vernon SW. Colorectal cancer screening by primary care physicians in two medical care organizations. Cancer Detect Prev. 2001;25:309–318.
Montano DE, Phillips WR, Kasprzyk D. Explaining physician rates of providing flexible sigmoidoscopy. Cancer Epidemiol Biomark Prev. 2000;9:665–669.
Schroy PC III, Geller AC, Wood MC, Page M, Sutherland L, Holm LJ, et al. Utilization of colorectal cancer screening tests: a1997 survey of Massachusetts internists. Prev Med. 2001;33:381–391.
Nadel MR, Shapiro JA, Klabunde CN, Seeff LC, Uhler R. mith RA et al. A national survey of primary care physicians’ methods for screening for fecal occult blood. Ann Intern Med. 2005;142:86–94.
Klabunde CN, Lanier D, Nadel MR, McLeod C, Yuan G, Vernon SW. Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007. Am J Prev Med. 2009;37:8–16.
Myers RE, Hyslop T, Gerrity M, Schlackman N, Hanchak N, Grana J, et al. Physician intention to recommend complete diagnostic evaluation in colorectal cancer screening. Cancer Epidemiol Biomark Prev. 1999;8:587–593.
Yabroff KR, Klabunde CN, Myers R, Brown M. Physician recommendations for follow-up of positive fecal occult blood test. Med Care Res Rev. 2005;62:79–110.
Bandura A. Social Foundations of Thought and Action: A Social Cognitive Theory. Englewood Cliffs, NJ: Prentice Hall; 1986.
Fishbein M, Ajzen I. Understanding attitudes and predicting social behavior. Englewood, NJ: Prentice Hall; 1980.
Klabunde CN, Frame PS, Meadow A, Jones E, Nadel M, Vernon SW. A national survey of primary care physicians’ colorectal cancer screening recommendations and practices. Prev Med. 2003;36:352–362.
Schwartz JS, Lewis CE, Clancy C, Kinosian MS, Radany MH, Koplan JP. Internists’ practices in health promotion and disease prevention A survey. Ann Intern Med (US). 1991;114:46–53.
Pham HH, Schrag D, Hargraves JL, Bach PB. Delivery of preventive services to older adults by primary care physicians. JAMA. 2005;294:473–481.
Lurie M, Slater J, McGovern P, Ekstrum J, Quam L, Margolis K. Preventive care for women: Does the sex of the physician matter? N Engl J Med. 1993;329:478–482.
Smith RA, Cokkinides V, Eyre HJ. American Cancer Society. American Cancer Society guidelines for the early detection of cancer, 2004. CA Cancer J Clin. 2004;54:41–52.
Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferucci J, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale - update based on new evidence. Gastroenterology. 2003;124:544–560.
Harrell FE Jr. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer-Verlag; 2001.
Physicians’ Recommendations for Guideline Consistent Colorectal Cancer Screening. http://healthservicescancergov/guidelineconsistentCRCscreening/. 2010;Accessed July 22, 2010.
Lafata JE, Simpkins J, Lamerato L, Poisson L, Divine G, Johnson CC. The economic impact of false-positive cancer screens. Cancer Epidemiol Biomark Prev. 2004;13:2126–2132.
Warren JL, Klabunde CN, Mariotto AB, Meekins A, Topor M, Brown ML, et al. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med. 2009;150:849–857.
Lansdorp-Vogelaar I, Van Ballegooijen M, Zauber AG, Boer R, Wilschut J, Habbema JDF. At what costs will screening with CT colonography be competitive? a cost effectiveness approach. Int J Cancer. 2008;124:1161–1168.
Turner BJ, Amsel Z, Lustbader E, Schwartz JS, Balshem A, Grisso JA. Breast cancer screening: effect of physician speciality, practice setting, year of medical school graduation, and sex. Am J Prev Med. 1992;8:78–85.
Haas JS, Fitzmaurice G, Brawarsky P, Liang S-Y, Hiatt RA, Klabunde CN, et al. Association of regional variation in primary care physicians’ colorectal cancer screening recommendations with individual use of colorectal cancer screening. Prev Chronic Dis. 2007;4:1–11.
Roetzheim RG, Pal N, Gonzalez EC, Ferrante JM, Van Durme DJ, Ayanian JZ, et al. The effects of physician supply on the early detection of colorectal cancer. J Fam Pract. 1999;48:850–858.
Garg AX, Adhikari NKJ, McDonald H, Rosas-Arellano MP, Devereaux PJ, Beyene J, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA. 2005;293:1223–1238.
Bodenheimer T, Grumbach K. Electronic technology: a spark to revitalize primary care? JAMA. 2003;290:259–264.
Yarnall KS, Pollak KI, Ostbye T, Krause KM, Michener JL. Primary care: is there enough time for prevention? Am J Public Health. 2003;93:635–641.
Montaño DE, Phillips WR. Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart adult. Am J Public Health. 1995;85:795–800.
Yeazel MW, Linstrom Bremer KM, Center BA. A validated tool for gaining insight into clinicians’ preventive medicine behaviors and beliefs: the preventive medicine attitudes and activities questionnaire (PMAAQ). Prev Med. 2006;43:86–91.
Acknowledgement
The survey was conducted under contract with Westat. Funding support was provided by the National Cancer Institute (contract numbers N02-PC-51308), the Agency for Healthcare Research and Quality (inter-agency agreement numbers Y3-PC-5019-01 and Y3-PC-5019-02) and the Centers for Disease Control and Prevention (interagency agreement number Y3-PC-6017-01). Presented in part at the American Public Health Association meeting November 10, 2009.
Conflict of Interest
None disclosed.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yabroff, K.R., Klabunde, C.N., Yuan, G. et al. Are Physicians’ Recommendations For Colorectal Cancer Screening Guideline-Consistent?. J GEN INTERN MED 26, 177–184 (2011). https://doi.org/10.1007/s11606-010-1516-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11606-010-1516-5